CEMR:F:F- (EUR)

ETF | Others |

Last Closing

USD 11.196

Change

+0.24 (+2.17)%

Market Cap

USD 0.50B

Volume

81.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 101.74B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.53 (-1.10%)

USD 101.37B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.47 (-0.90%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.20 (-1.42%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

+0.12 (+1.62%)

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

-3.24 (-3.57%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 45.80B
0ZC:F Zscaler Inc

-0.40 (-0.22%)

USD 37.92B
BSND:F Danone SA

-0.20 (-1.40%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

N/A

USD 24.77B

ETFs Containing CEMR:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.51% 72% C 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.51% 71% C- 70% C-
Trailing 12 Months  
Capital Gain 4.60% 84% B 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.60% 81% B- 63% D
Trailing 5 Years  
Capital Gain 71.90% 81% B- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 71.90% 81% B- 54% F
Average Annual (5 Year Horizon)  
Capital Gain 11.29% 72% C 67% D+
Dividend Return 11.29% 70% C- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.96% 46% F 82% B
Risk Adjusted Return 80.88% 78% C+ 84% B
Market Capitalization 0.50B 59% D- 48% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.